Efficient adaptation to environmental changes is pivotal for all bacterial cells. Almost all bacterial species depend on the conserved stringent response system to prompt timely transcriptional and metabolic responses according to stress conditions and nutrient depletion. The stringent response relies on the stress-dependent synthesis of the second messenger nucleotides and alarmones (p)ppGpp, which pleiotropically target and reprogram processes that consume cellular resources, such as ribosome biogenesis. Here we show that (p)ppGpp acts on the ribosome biogenesis GTPase A (RbgA) of Gram-positive bacteria. Using X-ray crystallography, hydrogen-deuterium exchange MS (HDX-MS) and kinetic analysis, we demonstrate that the alarmones (p)ppGpp bind to RbgA in a manner similar to that of binding by GDP and GTP and thereby act as competitive inhibitors. Our structural analysis of Staphylococcus aureus RbgA bound to ppGpp and pppGpp at 1.8 and 1.65 Å resolution, respectively, suggested that the alarmones (p)ppGpp prevent the active GTPase conformation of RbgA by sterically blocking the association of its G2 motif via their 3-pyrophosphate moieties. Taken together, our structural and biochemical characterization of RbgA in the context of the alarmone-mediated stringent response reveals how (p)ppGpp affects the function of RbgA and reprograms this GTPase to arrest the ribosomal large subunit.
Many
microorganisms possess the capacity for producing multiple
antibiotic secondary metabolites. In a few notable cases, combinations
of secondary metabolites produced by the same organism are used in
important combination therapies for treatment of drug-resistant bacterial
infections. However, examples of conjoined roles of bioactive metabolites
produced by the same organism remain uncommon. During our genetic
functional analysis of oxidase-encoding genes in the everninomicin
producer Micromonospora carbonacea var. aurantiaca, we discovered previously uncharacterized antibiotics everninomicin
N and O, comprised of an everninomicin fragment conjugated to the
macrolide rosamicin via a rare nitrone moiety. These metabolites were
determined to be hydrolysis products of everninomicin P, a nitrone-linked
conjugate likely the result of nonenzymatic condensation of the rosamicin
aldehyde and the octasaccharide everninomicin F, possessing a hydroxylamino
sugar moiety. Rosamicin binds the erythromycin macrolide binding site
approximately 60 Å from the orthosomycin binding site of everninomicins.
However, while individual ribosomal binding sites for each functional
half of everninomicin P are too distant for bidentate binding, ligand
displacement studies demonstrated that everninomicin P competes with
rosamicin for ribosomal binding. Chemical protection studies and structural
analysis of everninomicin P revealed that everninomicin P occupies
both the macrolide- and orthosomycin-binding sites on the 70S ribosome.
Moreover, resistance mutations within each binding site were overcome
by the inhibition of the opposite functional antibiotic moiety binding
site. These data together demonstrate a strategy for coupling orthogonal
antibiotic pharmacophores, a surprising tolerance for substantial
covalent modification of each antibiotic, and a potential beneficial
strategy to combat antibiotic resistance.
Significance
The increase in multidrug-resistant bacteria highlights the urgent need for compounds with novel target sites that can be developed as antibiotics. The argyrins represent a family of naturally produced octapeptides that display promising activity against
Pseudomonas aeruginosa
by inhibiting protein synthesis. Our structural and kinetic analyses reveal that argyrins inhibit protein synthesis by interacting with, and trapping, the translation elongation factor G (EF-G) on the ribosome, analogous to that reported previously for the unrelated antibiotic fusidic acid. However, the binding site of argyrin on EF-G is distinct from that of fusidic acid, indicating that intramolecular movements at the domain III/V interface of EF-G are also essential for facilitating late events in the translocation mechanism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.